DIAGNOSTIC TEST 119
Neurofilament Heavy Chain (pNfH)
Diagnostic test for pNfH. For suspicion of progressive ALS (amyotrophic lateral sclerosis).
Indication
Suspicion of progressive ALS (amyotrophic lateral sclerosis)
Sample material
CSF
- Minim. volume: 0,5 mL
Transport
- Within Sweden: frozen
- International: frozen
Method
ELISA
Reference interval
< 0.69 ng/mL normal, 0.69-1.52 ng/mL borderline
Result
Results are reported as normal, borderline or increased with a concentration (ng/mL).
Interpretation
Increased pNfH levels indicate neuronal/axonal damage in the central nervous system and correlates with levels of neurofilament light chain (NfL). High levels have been reported in ALS (amyotrophic lateral sclerosis) and support the diagnosis and prediction of disease progression.
References
- Behzadi A et al. Sci Rep. 2021. Neurofilaments can differentiate ALS subgroups and ALS from common diagnostic mimics. PMID: 34764380
- Mondesert E et al. Neurology. 2025. Comparative Performances of 4 Serum NfL Assays, pTau181, and GFAP in Patients With Amyotrophic Lateral Sclerosis. PMID: 40009787
Included in these panels
Need pricing information?
How to order
This test is available worldwide for hospitals, clinics, and physicians.
-
Print and complete the request form
Download the request form. Clearly state the name and phone number of the referring hospital, clinic, or physician. -
Prepare your samples
CSF: At least 0.5 mL CSF (polypropylene tubes).
-
Send samples and request form
Within Sweden
Send samples frozen to:
Envelopes and smaller boxes:
Wieslab AB, Box 50117, 20211 Malmö, Sweden
Larger boxes and frozen samples:
Wieslab AB, Lundavägen 151, 21224 Malmö, Sweden
International
Send samples frozen to:
Wieslab AB, Lundavägen 151, 21224 Malmö, Sweden
Last updated: 2025-11-25